Evidence map›Paper›PMID 34651367›Full record

ArticleJournal of peptide science : an official publication of the European Peptide Society2022

Clearance of oxytocin and its potentially enzyme resistant analogues in the OXT-receptor compartment of the potassium depolarized rat myometrium.

Vladimir Pliska, Guido Jutz

Open access · hybridAbstract read
In one paragraph

Article in Journal of peptide science : an official publication of the European Peptide Society, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Vladimir PliskaDepartment of Biology, Swiss Federal Institute of Technology (ETH), Zürich, Switzerland.ORCID https://orcid.org/0000-0002-3018-5742
Guido JutzDepartment of Biology, Swiss Federal Institute of Technology (ETH), Zürich, Switzerland.
ETH Zurich · CH

Funding

Swiss Federal Institute of Technology, ZürichSwiss National Science Foundation 50146Swiss National Science Foundation 5925Swiss National Science Foundation 8909
6 · The paper itself

Abstract

The time-response behaviour of a group of oxytocin analogues structurally modified on potential sites of oxytocin splitting by tissue inactivation enzymes ("enzyme probes") was investigated ex vivo on the potassium depolarized rat myometrium (at 30°C) and compared with the data obtained in the in vivo experiments. The modified oil-immersion method by Kalsner and Nickerson was used to record time profiles after cessation of a steady state myometrium contraction triggered by analogues in a high potassium tissue medium. An exchange of the aqueous medium for mineral oil enables to suppress return diffusion of the peptide and to record its irreversible clearance near the corresponding receptor compartment. Response records were analysed by a nonlinear numeric procedure based on combination of steady state and kinetic terms that allows concomitant estimations of affinities from time-response measurements, in the given case for analogues on depolarized myometrium. Potential inactivation-sensitive sites in the oxytocin chain are the Ν-terminal peptide bond Cys

Indexed as

MyometriumOxytocinReceptors, OxytocinAnimalsFemalePotassiumRatsUterine ContractionUterusOxytocinoxytocin receptor, ratPotassiumReceptors, Oxytocincarba-oxytocindeaminooxytocindepolarized uterus, ratoxytocin, enzymatic splittingoxytocin, ex vivo pharmacokineticsoxytocin, Free-Wilson analysisreceptor compartmentresponse kineticstime-response relationships

Identifiers

PMID34651367
PMCPMC9286045
OpenAlexW3207416058

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.